Skip to main content
. Author manuscript; available in PMC: 2021 Oct 25.
Published in final edited form as: Liver Transpl. 2019 Jul 24;25(9):1310–1320. doi: 10.1002/lt.25485

Table 2.

Univariate Competing Risk Analysis of Predictors of Wait-list Removal Due to Death or Too Sick

Predictor variables Sub HR (95 % CI) P Value
ALD (vs non-ALD) 0.89 (0.86–0.93) < 0.001

Age, yrs (vs 18–34)
 35–49 1.45 (1.32–1.61) < 0.001
 50–64 2.09 (1.89–2.31) < 0.001
 65 and older 2.96 (2.66–2.27) < 0.001

Female Sex 1.14 (1.10–1.17) < 0.001

Race (vs White)
 Black 1.04 (0.98–1.110) 0.22
 Other 1.17 (1.13–1.22) < 0.001

BMI (vs 20–29)
 Less than 20 1.41 (1.29–1.52) < 0.001
 30–34 0.99 (0.95–1.03) 0.92
 35–39 1.02 (0.97–1.07) 0.35
 > or = 40 1.25 (1.17–1.34) < 0.001

Blood group (vs AB)
 A 1.80 (1.62–2.00) < 0.001
 B 1.49 (1.33–1.66) < 0.001
 O 1.82 (1.64–2.02) < 0.001

Ascites (Absent)
 Slight 1.49 (1.41–1.57) < 0.001
 Moderate or more 2.75 (2.61–2.89) < 0.001

Spontaneous bacterial peritonitis 1.32 (1.25–1.40) < 0.001

Encephalopathy (vs none)
 Grade 1–2 1.50 (1.43–1.56) < 0.001
 Grade 3–4 5.00 (4.78–5.23) < 0.001

TIPSS 0.97 (0.91–1.02) 0.24

Portal vein thrombosis 1.04 (0.96–1.12) 0.33

Diabetes 1.21 (1.17–1.26) < 0.001

Prior malignancy 1.26 (1.18–1.34) < 0.001

MELD at listing (vs < 15)
 15–24 1.51 (1.45–1.56) < 0.001
 25–34 1.88 (1.79–1.98) < 0.001
 ≥ 35 2.75 (2.75–2.91) < 0.001

Region for listing, by grouping of wait-time (vs low)
 Moderate 1.31 (1.26–1.36) < 0.001
 Long 1.49 (1.44–1.55) < 0.001

Cohort (vs 2002–2006)
 2007–2011 1.15 (1.11–1.19) < 0.001
 2012–2016 1.16 (1.12–1.21) < 0.001